Cor Vasa 2010, 52(11-12):766-767 | DOI: 10.33678/cor.2010.191

Zpráva z kongresu - Heart Failure 2010

MUDr. Filip Málek, Ph.D.
Kardiologické oddělení, Nemocnice Na Homolce, Praha

Published: November 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Málek F. Zpráva z kongresu - Heart Failure 2010. Cor Vasa. 2010;52(11-12):766-767. doi: 10.33678/cor.2010.191.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pfisterer M, Buser P, Rickli H, et al.; TIME-CHF Investigators. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 2009;301:383-392. Go to original source... Go to PubMed...
    2. Pascual-Figal DA, Ordoñez-Llanos J, Tornel PL, et al.; MUSIC Investigators. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol 2009;54:2174-2179. Go to original source... Go to PubMed...
    3. Rehman SU, Mueller T, Januzzi Jr JL. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 2008;52:1458-1465. Go to original source... Go to PubMed...
    4. Moss AJ, Hall WJ, Cannom DS, et al.; MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338. Go to original source... Go to PubMed...
    5. Konstam MA, Poole Wilson PA, Dickstein K, et al. Design of the Heart failure Endpoint evaluation of AII-Antagonist Losartan (HEAAL) study in patients intolerant to ACE-inhibitor. Eur J Heart Fail 2008;10:899-906. Go to original source... Go to PubMed...
    6. Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-1675. Go to original source... Go to PubMed...
    7. Jiang W, O'Connor C, Silva SG, et al.; SADHART-CHF Investigators. Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J 2008;156:437-444. Go to original source... Go to PubMed...
    8. Anker SD, Comin Colet J, Filippatos G, et al.; FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-2448. Go to original source... Go to PubMed...
    9. Yancy CW, Chang SF, ADHERE Scientific Advisory Board and Investigators. Clinical characteristics and outcomes in patients admitted with heart failure with preserved systolic function: a report from the ADHERE database. J Card Fail 2003;9(Suppl.):S84. Go to original source...
    10. Felker GM, Benza RL, Chandler AB, et al.; OPTIME-CHF Investigators. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 2003;41:997-1003. Go to original source... Go to PubMed...
    11. Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009;360: 1705-1717. Go to original source... Go to PubMed...
    12. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-1898. Go to original source... Go to PubMed...
    13. Zannad F, Cohen-Solal A, Desnos M, et al. Clinical and etiological features, management and outcomes of acute heart failure: the EFICA cohort study. Eur Heart J 2002;4(Suppl.):579.
    14. Granger BB, Swedberg K, Ekman I, et al.; CHARM investigators. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005;366:2005-2011. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes